Also, the authors found that IgG/IgM/IgA aCL and IgA for anti-beta-2 glycoprotein I associated with increased risk of ischemic stroke, arterial thrombosis, atherosclerotic immune process, acute myocardial infarction, and peripheral vascular diseases [36]. This evidence concerns the gene CD79A and peripheral vascular disease.